Health System Design & National Pharmacare
Building a System That Delivers Today, and Endures Tomorrow. A sustainable healthcare system is one that can consistently deliver equitable access, high-quality care, and reliable supply, not just today, but for future generations. In Canada, prescription medicines are a critical component of that system. Yet access to these medicines, and the way they are funded, remains complex, fragmented, and evolving. At Vital, we view health system sustainability through the lens of the pharmaceutical supply chain, where policy decisions, funding models, and global market forces all intersect.
The Sustainability Challenge
Canada’s healthcare system is universal, but prescription drug coverage is not.
Today, access to medicines depends on a patchwork of public and private plans, varying widely across provinces, employers, and individuals.
This fragmentation creates key sustainability challenges such as uneven access to medications across populations; financial pressure on patients, employers, and governments; and complexity in administering and coordinating coverage.
While most Canadians have some form of coverage, gaps remain, leaving some without adequate access or facing significant out-of-pocket costs.
National Pharmacare as a System Evolution
National pharmacare proposals aim to address these gaps by expanding access to prescription drugs across Canada. From a system perspective, pharmacare is not just about coverage; it is about improving equitable access to medicines, strengthening purchasing power and cost management, and creating more consistent national standards. At the same time, implementation must preserve what works today, including existing public and private coverage models.
Our position reflects this balance:
Efforts to expand access should build on Canada’s current mixed system targeting gaps in coverage while preserving the strengths of existing public and private plans. A one-size-fits-all approach risks disrupting a system that already provides coverage for the majority of Canadians.
The Role of the Supply Chain in Sustainability
A sustainable health system depends on a resilient pharmaceutical supply chain. This includes reliable sourcing and distribution of medicines, predictable demand and funding structures, and efficient coordination between manufacturers, distributors, pharmacies, and payers. Policy changes, such as pharmacare, directly influence these dynamics.
Why It Matters
- Access Depends on Supply: Expanding coverage increases demand. The supply chain must be able to respond without disruption.
- Stability Requires Predictability: Sudden shifts in funding or reimbursement models can impact inventory planning, distribution flows, and supplier commitments.
- Global Forces Are Always at Play: Canada operates within a global pharmaceutical market. Pricing, availability, and innovation are shaped by international dynamics, not just domestic policy.
A Balanced Path Forward
Sustainable pharmacare must strike a careful balance between:
- Physical Access : Ensuring all Canadians, no matter their location, can obtain the medicines they need.
- Affordability : Managing costs for patients, employers, and governments.
- System Stability : Maintaining a predictable, reliable pharmaceutical supply chain.
Healthcare leaders increasingly recognize that achieving all three requires pragmatic,
collaborative solutions, not one-size-fits-all reforms.
Vital’s Perspective
At Vital, we believe health system sustainability depends on integration, not disruption.
We support approaches that:
- Expand access to medicines for underserved populations and those without adequate coverage
- Preserve and strengthen the existing mix of public and private coverage that serves most Canadians today
- Recognize the operational realities of the pharmaceutical supply chain
- Ensure policy decisions are aligned with global supply dynamics
A sustainable system must work end-to-end, from policy to patient.
Looking Ahead
Canada is at a pivotal moment in the evolution of its pharmaceutical system. As pharmacare policies continue to develop, success will depend on coordinated federal, provincial, and territorial collaboration; evidence-based policy design; and ongoing engagement with supply chain stakeholders.
The goal is clear: a system that delivers equitable access, financial sustainability, and supply reliability, all at once. Vital will continue to advocate for solutions that strengthen Canada’s healthcare system while safeguarding the integrity of its pharmaceutical supply chain.
Discover Our Advocacy Work
Our Advocacy in Action
Explore more of the key issues shaping Canada’s pharmaceutical supply chain and learn how Vital is advocating for a stronger, more resilient system. Discover our full advocacy work and the priorities driving meaningful change across the industry.
